Notably, this study included broad range of GLP-1 drugs, including much older GLP-1s that have far lower anti-obesity, anti-craving, and anti-addictive effects: abiglutide (Eperzan, Tanzeum), dulaglutide (Trulicity), exenatide (Byetta, Bydureon), liraglutide (Victoza, Saxenda), lixisenatide (Adlyxin, Lyxumia), semaglutide (Ozempic, Rybelsus, Wegovy) and tirzepatide (Mounjaro) Its possible that the associations that were found would be even stronger if the study had looked exclusively at semaglutide and tirzepatide, which are the current best-in-class options for weight loss
If your ultimate goal is to ween yourself off this medication, you need to commit to sustainable healthy behaviors once you stop taking this medication
Thank you KB Athena Sarmiento glowing skin, I always look for a brand that is effective and affordable
Konopleva M, Watt J, Contractor R, Tsao T, Harris D, Estrov Z, Bornmann W, Kantarjian H, Viallet J, Samudio I, Andreeff M
FA FA is a rare genetic disorder caused by mutations in at least 23 genes, known as FA genes, comprising FANC genes (A, B, C, D1, D2, E, F, G, I, J, L, M, N, O, P, Q, R, S, T, U, V, W, Y) that result in an impaired response to DNA damage
May 2026: 13 more lawsuits have been added to the federal NAION MDL against Novo Nordisk (Rybelsus) and other GLP-1 companies, bringing the total to 86
